Biomarin Pharmaceutical Inc (BMRN)
84.56
+1.59 +1.92%
NASDAQ
Jan 19, 10:16
USD
Biomarin Pharmaceutical Gross Profit Margin (Quarterly):
60.40% for Sept. 30, 2020View 4,000+ financial data types
Browse...
View Full Chart
Gross Profit Margin (Quarterly) Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Gross Profit Margin (Quarterly) Data
View and export this data going back to 2001.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Sept. 30, 2020 | 60.40% |
| June 30, 2020 | 77.19% |
| March 31, 2020 | 77.82% |
| Dec. 31, 2019 | 78.90% |
| Sept. 30, 2019 | 78.97% |
| June 30, 2019 | 80.03% |
| March 31, 2019 | 77.75% |
| Dec. 31, 2018 | 78.76% |
| Sept. 30, 2018 | 79.86% |
| June 30, 2018 | 78.81% |
| March 31, 2018 | 77.95% |
| Dec. 31, 2017 | 78.79% |
| Sept. 30, 2017 | 82.20% |
| June 30, 2017 | 82.26% |
| March 31, 2017 | 83.54% |
| Dec. 31, 2016 | 78.62% |
| Sept. 30, 2016 | 81.87% |
| June 30, 2016 | 82.80% |
| March 31, 2016 | 81.79% |
| Dec. 31, 2015 | 78.92% |
| Sept. 30, 2015 | 83.29% |
| June 30, 2015 | 84.78% |
| March 31, 2015 | 84.72% |
| Dec. 31, 2014 | 83.34% |
| Sept. 30, 2014 | 83.05% |
| June 30, 2014 | 83.73% |
| March 31, 2014 | 84.95% |
| Dec. 31, 2013 | 88.24% |
| Sept. 30, 2013 | 79.50% |
| June 30, 2013 | 83.50% |
| March 31, 2013 | 83.98% |
| Dec. 31, 2012 | 79.89% |
| Sept. 30, 2012 | 80.78% |
| June 30, 2012 | 80.99% |
| March 31, 2012 | 85.34% |
| Dec. 31, 2011 | 80.05% |
| Sept. 30, 2011 | 80.21% |
| June 30, 2011 | 82.59% |
| March 31, 2011 | 81.00% |
| Dec. 31, 2010 | 79.86% |
| Sept. 30, 2010 | 81.58% |
| June 30, 2010 | 84.34% |
| March 31, 2010 | 79.50% |
| Dec. 31, 2009 | 80.79% |
| Sept. 30, 2009 | 81.47% |
| June 30, 2009 | 76.03% |
| March 31, 2009 | 80.59% |
| Dec. 31, 2008 | 88.25% |
| Sept. 30, 2008 | 80.64% |
| June 30, 2008 | 85.05% |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Benchmarks
| Fluidigm Corp | 63.52% |
| Bristol-Myers Squibb Co | 76.26% |
| Tactile Systems Technology Inc | 71.24% |
Gross Profit Margin (Quarterly) Range, Past 5 Years
| Minimum | 60.40% | Sep 2020 |
| Maximum | 83.54% | Mar 2017 |
| Average | 78.86% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 25.47% |
| Return on Assets | 16.75% |
| Return on Invested Capital | 19.22% |
| Operating Margin (Quarterly) | -11.73% |
| Return on Net Operating Assets | 30.03% |
News
BioMarin's stock tumbles 6% after sharing data about experimental hemophilia A drug
Yahoo 01/11 10:58 ET
Yahoo 01/11 10:58 ET
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Biomarin Pharmaceutical Inc.
MT Newswires 01/11 10:25 ET
MT Newswires 01/11 10:25 ET
BioMarin Says Phase 3 Trial of Severe Hemophilia A Treatment Met All Primary, Secondary Endpoints
MT Newswires 01/11 04:52 ET
MT Newswires 01/11 04:52 ET
BioMarin's valoctocogene roxaparvovec gene therapy shows positive effect in hemophilia A
SA Breaking News 01/11 01:47 ET
SA Breaking News 01/11 01:47 ET
BofA's biopharma picks into 2021 set to build with new launches, 'beatable' expectations
SA Breaking News 01/05 18:37 ET
SA Breaking News 01/05 18:37 ET
Analysts predict M&A poised to rebound in next year, fueled by $1.47T in deal making capital
SA Breaking News 12/24 12:12 ET
SA Breaking News 12/24 12:12 ET
Advertisement
